RU2012156689A - METHOD FOR TREATING AN ENDOGENOUS INTOXICATION SYNDROME DUE TO HYPERPROTEOLYSIS - Google Patents

METHOD FOR TREATING AN ENDOGENOUS INTOXICATION SYNDROME DUE TO HYPERPROTEOLYSIS Download PDF

Info

Publication number
RU2012156689A
RU2012156689A RU2012156689/15A RU2012156689A RU2012156689A RU 2012156689 A RU2012156689 A RU 2012156689A RU 2012156689/15 A RU2012156689/15 A RU 2012156689/15A RU 2012156689 A RU2012156689 A RU 2012156689A RU 2012156689 A RU2012156689 A RU 2012156689A
Authority
RU
Russia
Prior art keywords
hyperproteolysis
treating
endogenous intoxication
antiproteolytic
dose
Prior art date
Application number
RU2012156689/15A
Other languages
Russian (ru)
Other versions
RU2524647C1 (en
Inventor
Виктор Васильевич Шилов
Валерий Юзефович Ковтун
Валерий Игоревич Саноцкий
Вадим Анатольевич Лукин
Original Assignee
Государственное Бюджетное Учреждение "Санкт-Петербургский Научно-Исследовательский Институт Скорой Помощи Им. И.И. Джанелидзе"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Бюджетное Учреждение "Санкт-Петербургский Научно-Исследовательский Институт Скорой Помощи Им. И.И. Джанелидзе" filed Critical Государственное Бюджетное Учреждение "Санкт-Петербургский Научно-Исследовательский Институт Скорой Помощи Им. И.И. Джанелидзе"
Priority to RU2012156689/15A priority Critical patent/RU2524647C1/en
Publication of RU2012156689A publication Critical patent/RU2012156689A/en
Application granted granted Critical
Publication of RU2524647C1 publication Critical patent/RU2524647C1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Способ лечения синдрома эндогенной интоксикации, обусловленного гиперпротеолизом, включающий стандартную детоксикационную терапию с применением антипротеолитических препаратов, отличающийся тем, что в качестве антипротеолитического препарата вводят амбен в дозе 50-250 мг внутривенно струйно в течение не менее трех суток с интервалом 3-4 ч и дополнительно вводят гепарин подкожно в дозе 250 ЕД 4 раза в сутки.A method of treating endogenous intoxication syndrome caused by hyperproteolysis, including standard detoxification therapy using antiproteolytic drugs, characterized in that, as an antiproteolytic drug, ambene is administered in a dose of 50-250 mg intravenously for at least three days with an interval of 3-4 hours and an additional heparin is administered subcutaneously in a dose of 250 IU 4 times a day.

Claims (1)

Способ лечения синдрома эндогенной интоксикации, обусловленного гиперпротеолизом, включающий стандартную детоксикационную терапию с применением антипротеолитических препаратов, отличающийся тем, что в качестве антипротеолитического препарата вводят амбен в дозе 50-250 мг внутривенно струйно в течение не менее трех суток с интервалом 3-4 ч и дополнительно вводят гепарин подкожно в дозе 250 ЕД 4 раза в сутки. A method of treating endogenous intoxication syndrome caused by hyperproteolysis, including standard detoxification therapy using antiproteolytic drugs, characterized in that, as an antiproteolytic drug, ambene is administered in a dose of 50-250 mg intravenously for at least three days with an interval of 3-4 hours and an additional heparin is administered subcutaneously in a dose of 250 IU 4 times a day.
RU2012156689/15A 2012-12-25 2012-12-25 Method of treating endogenous intoxication syndrome caused by hyperproteolysis RU2524647C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2012156689/15A RU2524647C1 (en) 2012-12-25 2012-12-25 Method of treating endogenous intoxication syndrome caused by hyperproteolysis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2012156689/15A RU2524647C1 (en) 2012-12-25 2012-12-25 Method of treating endogenous intoxication syndrome caused by hyperproteolysis

Publications (2)

Publication Number Publication Date
RU2012156689A true RU2012156689A (en) 2014-06-27
RU2524647C1 RU2524647C1 (en) 2014-07-27

Family

ID=51216142

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012156689/15A RU2524647C1 (en) 2012-12-25 2012-12-25 Method of treating endogenous intoxication syndrome caused by hyperproteolysis

Country Status (1)

Country Link
RU (1) RU2524647C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2609533C1 (en) * 2015-09-21 2017-02-02 Николай Викторович Мендрух Tooth-wheel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA75093C2 (en) * 2000-10-06 2006-03-15 Dimensional Pharm Inc Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors
RU2268038C2 (en) * 2001-01-17 2006-01-20 Маттиас Рат Synergetic composition containing ascorbate amd lysine for treatment of states associated with extracellular matrix destruction
RU2280455C2 (en) * 2004-02-05 2006-07-27 Галина Викторовна Сукоян Medicinal agent for arresting syndrome of systemic inflammatory response

Also Published As

Publication number Publication date
RU2524647C1 (en) 2014-07-27

Similar Documents

Publication Publication Date Title
EA201692159A1 (en) COMPOSITION FOR THE TREATMENT OF DIABETES CONTAINING CONJUGATE BASED ON ANALOGUE INSULIN LONG-TERM ACTION AND CONJUGATE BASED ON ANALOGUE LONG-TERM POTTIDE PULSE OF LONG-TERM
MX2021000898A (en) METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH).
EA201490377A1 (en) TREATMENT OF MULTIPLE SCLEROSIS BY COMBINATION OF LAKVINIMODE AND GLATIRAMER ACETATE
GB2507884A (en) Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current
EA201490911A1 (en) METHODS OF TREATMENT OF MALIGNANT TUMORS WITH THE USE OF ORAL COMPOSITIONS OF CYTIDINE ANALOGUES
EA201170669A1 (en) TREATMENT OF PYRPHENIDONE PATIENTS WITH ATYPICAL LIVER FUNCTION
EA201490254A1 (en) COMBINED TREATMENT OF HEPATITIS C
EA201490378A1 (en) TREATMENT OF MULTIPLE SCLEROSIS USING THE COMBINATION OF LACHINIMODA AND INTERFERON-β
RU2012156689A (en) METHOD FOR TREATING AN ENDOGENOUS INTOXICATION SYNDROME DUE TO HYPERPROTEOLYSIS
TW201613651A (en) Pharmaceutical composition containing polymerized camptothecin derivative and polymerized hsp90 inhibitor derivative
MX2023005014A (en) Methods of treating chronic inflammatory diseases.
PH12014502494A1 (en) Parenteral esmolol formulation
RU2012123182A (en) METHOD FOR CORRECTION OF MENTAL STATE OF PATIENTS AND ANTIOXIDANT STATUS IN ORGANIC DISORDER OF PERSONALITY
PH12017501005A1 (en) Injectable formulations of paracetamol
EA201590325A1 (en) IMPROVED CANCER TREATMENT WITH REDUCED RENAL TOXICITY
EA201591994A1 (en) CYSTEIN OR ITS DERIVATIVE FOR THE TREATMENT OF ATROPHIC GASTRITIS
UA71921U (en) Method for treating toxic neuroretinopathy of alcohol etiology
RU2009124823A (en) METHOD FOR TREATING A PATIENT WITH CHRONIC Brucellosis
EA201400424A1 (en) PHARMACEUTICAL COMPOSITION AND KIT FOR THE TREATMENT OF BACTERIAL INFECTIONS
UA89638U (en) Method for treating aged patients with syndrome of vascular cognitive impairment
RU2013143983A (en) METHOD OF CORRECTION OF IMMUNE DEFICIENCY IN CATTLE LEUKEMIS VIRUS INFECTED
UA69978U (en) Method for treatment of patients with primary erysipelas
RU2014142874A (en) A method of treating a hangover syndrome in persons not related to patients with alcoholism
RU2012128821A (en) METHOD FOR TREATING INFLUENZA AND INFLUENZAID DISEASES COMPLICATED BY PNEUMONIA
UA69690U (en) method for treating patients with fatigue syndrome on the background of chronic tonsillar infection

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20141226